INSIGHTS ON DRUG DEVELOPMENT
-
Amorphous Solids: Implications For Solubility And Stability
Amorphous solids can enhance drug solubility and bioavailability but introduce stability risks, making careful characterization and control essential for successful pharmaceutical development and manufacturing.
-
Overcoming Excipient Risks And Challenges For Parenteral Formulations
Excipients are essential to parenteral formulations, which help protect APIs, enhance stability, and ensure safety. Learn how strategic excipient selection can optimize drug performance and patient outcomes.
-
AustinPx Site Tour
Take a virtual tour of AustinPx to explore advanced facilities, including KinetiSol™ technology, and discover how we enable scalable, sustainable performance.
-
Application Of LC-UV/MS Workflows To Increase Efficiency
Discover how LC-UV/MS workflows help overcome analytical challenges in GLP-1 analog development to streamline impurity identification and boost lab efficiency in research.
-
Cost Modeling Analysis Of AAV And LV Manufacturing3/31/2026
Manufacturing scale plays a critical role in viral vector economics. Compare AAV and LV production scenarios to gain insight into how intermediate-scale strategies can reduce cost and risk.
-
Chirality In Drug Development: From Racemic Mixtures To Enantiopure Substances5/6/2026
Chiral crystallization enables efficient production of enantiopure drug substances, improving pharmacological control and safety while supporting scalable, cost‑effective small molecule development.
-
Assessing Production And Stability Of Antibody Drug Conjugate Platforms9/24/2025
ADCs with similar antibody sequences can behave differently due to linker and payload choices. Analytical tools reveal structural and stability differences critical to therapeutic performance.
-
Combining Patient Centricity And Commercial Viability In Pediatric Product Development8/15/2024
Medication acceptance and adherence are critical concerns in pediatric populations due to these patients’ rapid anatomical and physiological development.
-
FAIR Data—What Does It Mean For The Lab Scientist?6/18/2026
Over 70% of scientists don't know FAIR data, but it is key to AI and reproducibility. Learn how structured data transforms research efficiency and unlocks long-term value across R&D.
DRUG DEVELOPMENT SOLUTIONS
-
Societal specializes in modified-release formulations, including those for high potent and DEA controlled substances.
-
Cambrex holds US Drug Enforcement Agency (DEA) licenses for process research, development, manufacturing, and importation of Schedule I to IV controlled substances.
-
Gain human-relevant insights with patient-derived assay-ready organoids.
-
Purchasing buffer formulation equipment involves more than just price. Explore critical features, budget considerations, and vendor qualifications to secure a reliable system that meets your needs.
-
LMD 6 Laser Microdissection Microscope
Dissection Perfection
Laser Microdissection (LMD, also known as Laser Capture Microdissection or LCM) enables users to isolate specific single cells or entire areas of tissue. Powered by a unique laser design and dynamic software, Leica LMD systems allow users to easily isolate Regions of Interest (ROI) from entire areas of tissue down to single cells or even subcellular structures such as chromosomes.
LMD is typically used in genomics (DNA), transcriptomics (mRNA, miRNA), proteomics, metabolomics, and even next generation sequencing (NGS). Researchers in neurology, cancer research, plant analysis, forensics or climate research rely on this method. Furthermore, LMD is a perfect tool for live cell culture (LCC), for cloning and re-cultivation, manipulation or downstream analysis.
We move the laser, not the sample. And we use gravity for collection. That is why our LMD systems provide you with perfectly cut, contamination-free, analysis-ready dissectates.